Weight Loss Injections: How Do GLP-1 Medications Work and What Role Does Nutrition Play?

The so-called “weight loss shot” has become one of the most widely discussed developments in weight management. Medications such as semaglutide and tirzepatide can help eligible patients achieve significant weight loss. At the same time, interest is growing in the role that nutrition, physical activity, and dietary supplements may play alongside these medications.

But what exactly is behind the weight loss shot? Who may be a candidate for this type of treatment? What can these medications do—and what are their limitations? And what role do nutrition and so-called GLP-1 supplements actually play?

A closer look at how these medications work and what current research shows can help put the topic into perspective.

What Is the “Weight Loss Shot”?

“Weight loss shot” is not a medical term. In the United States, the term generally refers to prescription medications that are used under specific medical circumstances to treat overweight and obesity.

One well-known medication is semaglutide, the active ingredient in Wegovy. Semaglutide belongs to a class of medications called GLP-1 receptor agonists.

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the body that plays a role in appetite regulation, satiety, and glucose metabolism.

Semaglutide mimics some of the effects of naturally occurring GLP-1 by activating the GLP-1 receptor. Tirzepatide, the active ingredient in Zepbound, acts on both the GIP and GLP-1 receptors, thereby targeting two hormonal signaling pathways.

Weight loss does not occur simply because these medications “burn fat.” An important part of their effect is that they influence hunger, appetite, and feelings of fullness, which can reduce overall food and calorie intake.

In clinical studies, semaglutide has been associated with reduced appetite and increased feelings of fullness, helping many patients consume fewer calories.

Who May Be a Candidate for a Weight Loss Medication?

GLP-1-based and related medications are not intended for everyone who wants to lose a few pounds.

In the United States, Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management in adults with:

• A BMI of 30 or greater, which falls within the obesity range; or
• A BMI of 27 or greater with at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

These medications are used together with a reduced-calorie diet and increased physical activity. The specific indication, dosing, contraindications, warnings, and eligibility criteria depend on the medication and the individual patient's medical history.

This means that a weight loss medication is not simply intended as a quick solution for losing a few pounds. It is part of a medical approach to chronic weight management when a person meets the appropriate criteria.

A Weight Loss Medication Is One Tool—Not the Whole Solution

Current evidence shows that GLP-1-based and related medications can be effective tools for weight management in appropriately selected patients. At the same time, research makes clear that medication is not appropriate for everyone and should not be viewed as the only component of a long-term weight-management strategy.

Potential Benefits

• Significant weight loss: Clinical trials have shown that many people with obesity or overweight can achieve substantial weight loss with medications such as semaglutide and tirzepatide. In a major 68-week trial of once-weekly semaglutide 2.4 mg, average weight loss was approximately 15% of initial body weight.
• Effects on hunger and fullness: These medications can reduce hunger and increase feelings of fullness. This may make it easier for patients to reduce overall calorie intake.
• Metabolic benefits: Depending on the medication and the individual's health status, treatment may also improve blood glucose and other cardiometabolic risk factors.
• Additional support: Medication may be particularly helpful for people who have not achieved sufficient weight loss through nutrition and physical activity alone.

What Are the Limitations?

Possible Side Effects

Like all prescription medications, GLP-1-based and related therapies can cause side effects.

Common gastrointestinal side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Feelings of fullness

These effects may be particularly noticeable when treatment begins or when the dose is increased.

Weight Loss May Include Lean Mass

When someone loses a substantial amount of weight, the change is not limited to body fat. Lean mass can also be lost.

A 2026 systematic review and meta-analysis of 20 randomized controlled trials involving more than 15,000 participants found that approximately 25% to 39% of weight lost during treatment with incretin-based medications was lean mass, depending on the medication. The analysis also found that lifestyle intervention combined with resistance training was associated with a more favorable proportion of lean-mass preservation.

This is one reason why maintaining adequate protein intake and incorporating resistance training can be important components of a weight-management plan.

Weight Can Increase After Treatment Stops

Weight regain can occur after GLP-1 medication is discontinued.

In the STEP 1 trial extension, participants who stopped semaglutide regained approximately two-thirds of their previous weight loss within one year.

This does not mean that every person will regain the same amount of weight. It does, however, highlight the importance of considering weight management as a long-term process rather than a short-term intervention.

Individual Responses Vary

The amount of weight a person loses can vary considerably. Factors include the individual's starting weight, the medication used, dosage, treatment duration, medical history, tolerance, and accompanying lifestyle changes.

What Does a Weight Loss Medication Mean for Your Diet?

One common question is:

Can you still eat whatever you want while taking a weight loss medication?

There is no universal list of foods that everyone must avoid during GLP-1 treatment. However, appetite and food intake often change significantly.

As people eat less overall, the nutritional quality of the foods they do eat becomes increasingly important.

A balanced eating pattern should provide adequate:

• Protein
• Dietary fiber
• Vitamins
• Minerals
• Healthy fats
• Other essential nutrients

Nutrient-dense foods may include:

• Vegetables and fruit
• Beans, lentils, and other legumes
• Whole grains
• Protein-rich foods such as fish, eggs, dairy products, lean meats, and plant-based protein sources
• Nuts and seeds
• Healthy plant oils

During the beginning of treatment or after a dose increase, some people may experience nausea, fullness, constipation, diarrhea, or other gastrointestinal symptoms. These effects can also influence which foods are easiest to tolerate.

The question is therefore less about “What am I allowed to eat?” and more about how to adapt a balanced, nutrient-dense eating pattern to changes in appetite and individual tolerance.

Protein and Muscle Mass: An Important Focus

During significant weight loss, the number on the scale is only part of the picture. Body composition matters, too.

Protein provides the amino acids the body needs to maintain and build muscle tissue. Adequate protein intake may therefore help support the preservation of lean mass during weight loss.

Exercise is an important part of this equation.

Resistance training provides a direct stimulus for maintaining muscle, while protein supplies the building blocks needed to support muscle tissue.

Current evidence therefore supports paying attention not only to calorie intake and total weight loss but also to body composition. Regular resistance training may be particularly useful when the goal is to preserve muscle during weight reduction.

Important components of a nutrition and activity strategy during weight loss include:

• Adequate protein intake
• A varied, nutrient-dense diet
• Regular resistance and aerobic exercise
• Adequate hydration

GLP-1 Supplements: What's Behind the Claims?

As GLP-1 medications have become more widely known, dietary supplements marketed as “GLP-1 support,” “GLP-1 boosters,” or “natural GLP-1 support” have also appeared.

There is no single, medically standardized category of “GLP-1 supplements.” Depending on the product, ingredients may include:

• Dietary fiber, such as psyllium or inulin
• Protein
• Prebiotics
• Selected botanical compounds, such as berberine

The more important question is therefore not whether a product uses the term “GLP-1” in its marketing, but what its actual ingredients are and what scientific evidence supports those ingredients.

The key difference between these products and prescription GLP-1 medications is their mechanism of action.

Medications such as semaglutide and tirzepatide are specifically designed to activate defined hormonal signaling pathways. Dietary supplements generally act through different physiological mechanisms.

They therefore do not have the same pharmacological effects as prescription GLP-1 medications.

Some ingredients may nevertheless influence physiological processes related to satiety, digestion, gut microbiota, or metabolism.

Dietary Fiber: Supporting Satiety and Digestion

Dietary fiber is one of the most interesting components of a healthy eating pattern when it comes to satiety, digestion, and metabolic health.

Fiber naturally occurs in:

• Vegetables
• Beans and other legumes
• Whole grains
• Fruit
• Nuts
• Seeds

Certain soluble and fermentable fibers can influence digestion and contribute to feelings of fullness.

When fermentable fiber is broken down by gut bacteria, it produces short-chain fatty acids (SCFAs). These compounds can influence signaling pathways involved in appetite regulation and may stimulate the release of hormones such as GLP-1 and peptide YY (PYY).

This makes dietary fiber an interesting example of how nutrition can influence naturally occurring physiological processes.

However, this should not be interpreted as meaning that fiber has the same pharmacological effect as a GLP-1 medication.

The evidence suggests that fiber can be a valuable part of a balanced eating pattern and may support satiety, digestive health, and metabolic health.

Berberine and Other Botanical Compounds

Berberine and various botanical extracts are also being studied in connection with metabolism and weight management.

Berberine is a naturally occurring compound found in several plants and is sold in the United States as a dietary supplement.

Research has examined potential effects on glucose metabolism, blood lipids, and body weight.

A 2026 systematic review and meta-analysis of 23 studies found statistically significant but relatively modest reductions in body weight, BMI, and waist circumference among participants taking berberine. However, the researchers also noted methodological limitations and differences among the studies, meaning the results should be interpreted cautiously.

Berberine therefore remains an area of ongoing research rather than an equivalent alternative to prescription weight-loss medications.

As with many bioactive compounds, the potential effects depend on the specific ingredient, dose, formulation, duration of use, and quality of the available evidence.

GLP-1 Medications and Nutrition: Two Different Approaches

GLP-1 medications and nutrition work through different pathways.

Medications such as semaglutide and tirzepatide are specifically designed to influence hormonal signaling involved in appetite, satiety, and metabolism and have been evaluated extensively in clinical trials.

Nutrition and dietary supplements take a broader approach.

Protein, dietary fiber, certain botanical compounds, and an overall nutrient-dense eating pattern can influence a variety of physiological processes related to satiety, digestion, gut health, and metabolism.

The strength of the evidence varies considerably depending on the nutrient or compound.

Dietary supplements should therefore not be equated with pharmacological GLP-1 therapy.

At the same time, that does not mean they are physiologically irrelevant.

The important questions are:

What is the ingredient?
How much is being used?
What is it intended to do?
And how strong is the scientific evidence supporting that specific use?

For many people, a sensible approach to weight management begins with the fundamentals: a balanced eating pattern, regular physical activity, adequate sleep, and a sustainable long-term approach to nutrition.

Dietary supplements may complement certain aspects of nutrition when there is a reasonable evidence-based rationale for their use.

What Remains Important Long Term?

With or without medication, a sustainable eating pattern and regular physical activity remain important components of long-term weight management.

The goal is not necessarily to restrict food as much as possible. Instead, food quality becomes especially important when overall food intake decreases.

Key considerations include:

• Adequate protein
• A varied selection of nutrient-dense foods
• Adequate dietary fiber
• Sufficient vitamins and minerals
• Regular physical activity, including resistance training
• Adequate hydration

Viewed this way, GLP-1 medications, nutrition, exercise, and—in appropriate circumstances—dietary supplements are not necessarily competing concepts.

They address different aspects of weight management and may have different roles depending on the individual's medical and nutritional needs.

Conclusion: Putting Weight Loss Medications, Nutrition, and Supplements Into Perspective

GLP-1-based and related medications such as semaglutide and tirzepatide have expanded the options available for medical weight management.

Their effects have been extensively studied, and for people who meet the appropriate medical criteria, they can be an important component of treatment.

At the same time, they are not the entire solution.

The quality of weight loss, adequate nutrient intake, preservation of muscle mass, physical activity, and sustainable long-term habits all remain important considerations.

Nutrition and certain dietary supplements may also influence physiological processes related to satiety, digestion, nutrient intake, and metabolism. Dietary fiber, protein, and selected botanical compounds remain active areas of research.

The key question is therefore not necessarily “Weight loss medication or nutrition?”

Instead, it is:

What approach is appropriate for the individual's situation, and how can the different components of a long-term weight-management plan work together?

Scientific Disclaimer

This article is provided for general educational and informational purposes only. It is not intended to replace medical advice, diagnosis, or treatment from a qualified healthcare professional.

Information about dietary supplements does not constitute a recommendation to take any particular product or ingredient. Dietary supplements are not a substitute for prescription medications or medical treatment.

Whether a prescription medication for weight management is appropriate depends on an individual's medical history, current health, medications, risk factors, and other considerations. Treatment decisions should be made in consultation with a qualified healthcare professional.

References

1.   U.S. Food and Drug Administration (FDA): Wegovy (semaglutide) Prescribing Information and FDA approval information.

2.   U.S. Food and Drug Administration (FDA): Zepbound (tirzepatide) — Chronic Weight Management.

3.   Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.

4.   Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022.

5.   Eisa N, Barood O. Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Diabetes, Obesity and Metabolism. 2026.

6.   The role of dietary fibers in regulating appetite: an overview of mechanisms and weight consequences. Critical Reviews in Food Science and Nutrition. 2023.

7.   Vahed IE et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. International Journal of Obesity. 2026.

8.   de Jong JCB et al. Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review. Frontiers in Endocrinology. 2026.